Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedSite-wide notices were added about a lapse in government funding and the NIH Clinical Center status, and a new release note (Revision: v3.4.1) was added; the previous release note (Revision: v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check10 days agoChange DetectedGlossary display has been added, and the UI now explains how added and deleted items are color-coded. The 'No FEAR Act data' section was removed and the revision label was updated to v3.4.0.SummaryDifference1.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision history updated to include Revision: v3.3.4 and remove Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page history shows a new Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the Study Record History.SummaryDifference0.1%

- Check82 days agoChange DetectedRemoved the government funding/disclaimer notice at the top of the page; the rest of the content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.